- Home
- MGEE vs TMDX Comparison
MGEE vs TMDX Comparison
Compare MGEE & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MGEE | TMDX |
|---|---|---|
| Founded | 1855 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 2001 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MGEE | TMDX |
|---|---|---|
| Price | $70.63 | $81.52 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 12 |
| Target Price | $76.80 | ★ $97.30 |
| AVG Volume (30 Days) | 166.5K | ★ 631.9K |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | ★ 2.89% | N/A |
| EPS Growth | 11.71 | ★ 382.18 |
| EPS | ★ 1.32 | 0.61 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | $7.69 | $22.50 |
| Revenue Next Year | $4.97 | $17.93 |
| P/E Ratio | ★ $53.28 | $135.46 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $68.01 | $60.11 |
| 52 Week High | $87.94 | $156.00 |
Technical Indicators
Market Signals| Indicator | MGEE | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 30.33 | 43.69 |
| Support Level | $68.01 | $80.29 |
| Resistance Level | $81.83 | $90.67 |
| Average True Range (ATR) | 1.60 | 3.68 |
| MACD | -0.05 | -0.67 |
| Stochastic Oscillator | 25.38 | 30.81 |
Price Performance
Historical ComparisonAbout MGEE MGE Energy Inc
MGE Energy provides electric service to 170,000 customers and natural gas service to 180,000 customers in Madison, Wisconsin, and surrounding areas. Nearly 90% of customers are residential. The company also owns a 3.6% stake in American Transmission Co. MGE owns interests in two coal power plants that earn guaranteed fixed rates of return, contributing about 20% of earnings.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.